Location History:
- Le Mont-sur-Lausanne, CH (2021)
- Lausanne, CH (2023)
Company Filing History:
1 out of 1 
1 out of 2 
1 out of 1 Years Active: 2021-2023
Title: Innovations by Thierry Pedrazzini in Cardiac Health
Introduction
Thierry Pedrazzini is a notable inventor based in Le Mont-sur-Lausanne, Switzerland. He has made significant contributions to the field of cardiac health through his innovative research and inventions. With a total of two patents, his work focuses on the diagnostic and therapeutic uses of long noncoding RNAs in relation to heart disorders.
Latest Patents
Thierry Pedrazzini's latest patents include groundbreaking methods for diagnosing, monitoring, and prognosticating primary and secondary cardiac disorders based on lncRNA expression. His first patent provides methods for predicting heart failure after myocardial infarction and differentiating between ischemic and non-ischemic heart failure. The assessment of these lncRNAs serves as a marker for monitoring drug-induced cardiac toxicities and assessing cardiac involvement during systemic diseases. His second patent relates to the therapeutic uses of lncRNAs for treating cardiac pathologies, offering new avenues for regenerative medicine.
Career Highlights
Throughout his career, Thierry Pedrazzini has worked with esteemed organizations such as Firalis SA and the Luxembourg Institute of Health. His experience in these institutions has allowed him to advance his research and contribute to the understanding of cardiac health.
Collaborations
Thierry Pedrazzini has collaborated with notable professionals in his field, including Samir Ounzain and Hueseyin Firat. These collaborations have further enriched his research and innovations.
Conclusion
Thierry Pedrazzini's contributions to cardiac health through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in diagnosing and treating heart disorders.